{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:02:52Z","timestamp":1784818972276,"version":"3.55.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"DOI":"10.1007\/s00702-026-03243-8","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:25:07Z","timestamp":1784816707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Large language models as a screening tool for the qualification of patients with Parkinson\u2019s disease for device-aided therapies"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2722-9790","authenticated-orcid":false,"given":"Pawe\u0142","family":"Pobudejski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3693-9565","authenticated-orcid":false,"given":"Mateusz","family":"To\u015b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Nyczka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5842-3837","authenticated-orcid":false,"given":"Krzysztof","family":"Duda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6022-7731","authenticated-orcid":false,"given":"Tomasz","family":"Chmiela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0340-660X","authenticated-orcid":false,"given":"Joanna","family":"Siuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"3243_CR1","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41746-025-01963-x","volume":"8","author":"M Agrawal","year":"2025","unstructured":"Agrawal M, Chen IY, Gulamali F, Joshi S (2025) The evaluation illusion of large language models in medicine. Npj Digit Med 8:600. https:\/\/doi.org\/10.1038\/s41746-025-01963-x","journal-title":"npj Digit Med"},{"key":"3243_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2217\/nmt-2020-0021","volume":"10","author":"J Aldred","year":"2020","unstructured":"Aldred J, Anca-Herschkovitsch M, Antonini A et al (2020) Application of the \u20185-2-1\u2019 screening criteria in advanced Parkinson\u2019s disease: interim analysis of DUOGLOBE. Neurodegener Dis Manag 10:309\u2013323. https:\/\/doi.org\/10.2217\/nmt-2020-0021","journal-title":"Neurodegener Dis Manag"},{"key":"3243_CR3","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1080\/03007995.2018.1502165","volume":"34","author":"A Antonini","year":"2018","unstructured":"Antonini A, Stoessl AJ, Kleinman LS et al (2018) Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson\u2019s disease: a multi-country Delphi-panel approach. Curr Med Res Opin 34:2063\u20132073. https:\/\/doi.org\/10.1080\/03007995.2018.1502165","journal-title":"Curr Med Res Opin"},{"key":"3243_CR4","unstructured":"Antonini A, Odin P, Alobaidi A et al (2020) Demonstrating the clinical value of MANAGE-PD tool in assessing symptom control of Parkinson\u2019s disease patients: evidence from G7 countries"},{"key":"3243_CR5","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s40263-022-00963-9","volume":"36","author":"A Antonini","year":"2022","unstructured":"Antonini A, Pahwa R, Odin P et al (2022) Comparative effectiveness of device-aided therapies on quality of life and off-time in advanced Parkinson\u2019s disease: a systematic review and Bayesian network meta-analysis. CNS Drugs 36:1269\u20131283. https:\/\/doi.org\/10.1007\/s40263-022-00963-9","journal-title":"CNS Drugs"},{"key":"3243_CR6","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00702-023-02668-9","volume":"130","author":"M Auffret","year":"2023","unstructured":"Auffret M, Weiss D, Stocchi F et al (2023) Access to device-aided therapies in advanced Parkinson\u2019s disease: navigating clinician biases, patient preference, and prognostic uncertainty. J Neural Transm (Vienna) 130:1411\u20131432. https:\/\/doi.org\/10.1007\/s00702-023-02668-9","journal-title":"J Neural Transm (Vienna)"},{"key":"3243_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","volume":"27","author":"R Balestrino","year":"2020","unstructured":"Balestrino R, Schapira AHV (2020) Parkinson disease. Eur J Neurol 27:27\u201342. https:\/\/doi.org\/10.1111\/ene.14108","journal-title":"Eur J Neurol"},{"key":"3243_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering12101059","volume":"12","author":"KS Bhalala","year":"2025","unstructured":"Bhalala KS, Mansoor H (2025) PARKA AI: a sensor-integrated mobile application for Parkinson\u2019s disease monitoring and self-management. Bioengineering (Basel, Switzerland) 12:1059. https:\/\/doi.org\/10.3390\/bioengineering12101059","journal-title":"Bioengineering (Basel, Switzerland)"},{"key":"3243_CR9","unstructured":"Bommasani R, Hudson DA, Adeli E et al (2022) On the opportunities and risks of foundation models"},{"key":"3243_CR10","unstructured":"Brown TB, Mann B, Ryder N et al (2020) Language models are few-shot learners"},{"key":"3243_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/NHH.0000000000000398","volume":"34","author":"T Capriotti","year":"2016","unstructured":"Capriotti T, Terzakis K (2016) Parkinson disease. Home Healthc Now 34:300\u2013307. https:\/\/doi.org\/10.1097\/NHH.0000000000000398","journal-title":"Home Healthc Now"},{"key":"3243_CR12","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3233\/JPD-225105","volume":"13","author":"KR Chaudhuri","year":"2023","unstructured":"Chaudhuri KR, Kov\u00e1cs N, Pontieri FE et al (2023) Levodopa carbidopa intestinal gel in advanced Parkinson\u2019s disease: DUOGLOBE final 3-year results. J Parkinson\u2019s Dis 13:769\u2013783. https:\/\/doi.org\/10.3233\/JPD-225105","journal-title":"J Parkinson\u2019s Dis"},{"key":"3243_CR13","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s44286-025-00219-5","volume":"2","author":"G Chen","year":"2025","unstructured":"Chen G, Tat T, Zhou Y et al (2025) Neural network-assisted personalized handwriting analysis for Parkinson\u2019s disease diagnostics. Nat Chem Eng 2:358\u2013368. https:\/\/doi.org\/10.1038\/s44286-025-00219-5","journal-title":"Nat Chem Eng"},{"key":"3243_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1351808","volume":"12","author":"I Denham","year":"2024","unstructured":"Denham I, Maurin R, Deltetto I et al (2024) Levodopa-based device-aided therapies for the treatment of advanced Parkinson\u2019s disease: a social return on investment analysis. Front Public Health 12:1351808. https:\/\/doi.org\/10.3389\/fpubh.2024.1351808","journal-title":"Front Public Health"},{"key":"3243_CR16","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1111\/ene.15386","volume":"29","author":"G Deuschl","year":"2022","unstructured":"Deuschl G, Antonini A, Costa J et al (2022) European academy of neurology\/movement disorder society - European section guideline on the treatment of Parkinson\u2019s disease: I. Invasive therapies. Eur J Neurol 29:2580\u20132595. https:\/\/doi.org\/10.1111\/ene.15386","journal-title":"Eur J Neurol"},{"key":"3243_CR17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.5603\/pjnns.99624","volume":"58","author":"K Duda","year":"2024","unstructured":"Duda K, Chmiela T, Cie\u015bla-Fu\u0142awka A et al (2024) Are 5-2-1 Delphi criteria and MANAGE-PD useful screening tools for general neurologists for qualification to device-aided therapies in advanced Parkinson\u2019s disease? Neurol Neurochir Pol 58:422\u2013428. https:\/\/doi.org\/10.5603\/pjnns.99624","journal-title":"Neurol Neurochir Pol"},{"key":"3243_CR18","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1007\/s10072-024-07580-y","volume":"45","author":"M Erdogan","year":"2024","unstructured":"Erdogan M (2024) Evaluation of responses of the large language model GPT to the neurology question of the week. Neurol Sci 45:4605\u20134606. https:\/\/doi.org\/10.1007\/s10072-024-07580-y","journal-title":"Neurol Sci"},{"key":"3243_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1212\/WNL.58.1.156","volume":"58","author":"S Frucht","year":"2002","unstructured":"Frucht S, Greene PE (2002) An algorithm (decision tree) for the management of Parkinson\u2019s disease (2001): treatment guidelines. Neurology 58:156\u2013157. https:\/\/doi.org\/10.1212\/WNL.58.1.156","journal-title":"Neurology"},{"key":"3243_CR20","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR et al (2008) Movement disorder society-sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS\u2010UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129\u20132170. https:\/\/doi.org\/10.1002\/mds.22340","journal-title":"Mov Disord"},{"key":"3243_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2024.0666","volume":"86","author":"JR Harrison","year":"2025","unstructured":"Harrison JR, Tang SL, Burston B et al (2025) Large language models: a paradigm shift for dementia diagnosis and care. Br J Hosp Med 86:1\u201319. https:\/\/doi.org\/10.12968\/hmed.2024.0666","journal-title":"Br J Hosp Med"},{"key":"3243_CR22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17:427\u2013427. https:\/\/doi.org\/10.1212\/WNL.17.5.427","journal-title":"Neurology"},{"key":"3243_CR23","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S1474-4422(18)30239-4","volume":"17","author":"R Katzenschlager","year":"2018","unstructured":"Katzenschlager R, Poewe W, Rascol O et al (2018) Apomorphine subcutaneous infusion in patients with Parkinson\u2019s disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial. Lancet Neurol 17:749\u2013759. https:\/\/doi.org\/10.1016\/S1474-4422(18)30239-4","journal-title":"Lancet Neurol"},{"key":"3243_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.parkreldis.2020.12.024","volume":"83","author":"R Katzenschlager","year":"2021","unstructured":"Katzenschlager R, Poewe W, Rascol O et al (2021) Long-term safety and efficacy of apomorphine infusion in Parkinson\u2019s disease patients with persistent motor fluctuations: results of the open-label phase of the TOLEDO study. Parkinsonism Relat Disord 83:79\u201385. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.12.024","journal-title":"Parkinsonism Relat Disord"},{"key":"3243_CR25","unstructured":"Kim Y, Russell J, Karpinska M, Iyyer M (2025) One ruler to measure them all. Benchmarking multilingual long-context language models"},{"key":"3243_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/00002826-198406000-00008","volume":"7","author":"TA Larsen","year":"1984","unstructured":"Larsen TA, Calne S, Calne DB (1984) Assessment of Parkinson\u02bcs disease. Clin Neuropharmacol 7:165\u2013170. https:\/\/doi.org\/10.1097\/00002826-198406000-00008","journal-title":"Clin Neuropharmacol"},{"key":"3243_CR27","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMsr2214184","volume":"388","author":"P Lee","year":"2023","unstructured":"Lee P, Bubeck S, Petro J (2023) Benefits, limits, and risks of GPT-4 as an AI chatbot for medicine. N Engl J Med 388:1233\u20131239. https:\/\/doi.org\/10.1056\/NEJMsr2214184","journal-title":"N Engl J Med"},{"key":"3243_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.patter.2024.100943","volume":"5","author":"V Li\u00e9vin","year":"2024","unstructured":"Li\u00e9vin V, Hother CE, Motzfeldt AG, Winther O (2024) Can large language models reason about medical questions? Patterns (New York, N.Y.) 5:100943. https:\/\/doi.org\/10.1016\/j.patter.2024.100943","journal-title":"Patterns (New York, N.Y.)"},{"key":"3243_CR29","doi-asserted-by":"publisher","first-page":"e73212","DOI":"10.2196\/73212","volume":"27","author":"NV Maiorana","year":"2025","unstructured":"Maiorana NV, Marceglia S, Treddenti M et al (2025) Large language models in neurological practice: real-world study. J Med Internet Res 27:e73212\u2013e73212. https:\/\/doi.org\/10.2196\/73212","journal-title":"J Med Internet Res"},{"issue":"1","key":"3243_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-022-02560-1","volume":"22","author":"IA Malaty","year":"2022","unstructured":"Malaty IA, Martinez-Martin P, Chaudhuri KR et al (2022) Does the 5\u20132\u2009\u2212\u20091 criteria identify patients with advanced Parkinson\u2019s disease? Real-world screening accuracy and burden of 5\u20132-1-positive patients in 7 countries. BMC Neurol 22(1):35. https:\/\/doi.org\/10.1186\/s12883-022-02560-1","journal-title":"BMC Neurol"},{"key":"3243_CR31","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s00702-023-02656-z","volume":"130","author":"HR Moes","year":"2023","unstructured":"Moes HR, Henriksen T, S\u0142awek J et al (2023a) Tools and criteria to select patients with advanced Parkinson\u2019s disease for device-aided therapies: a narrative review. J Neural Transm 130:1359\u20131377. https:\/\/doi.org\/10.1007\/s00702-023-02656-z","journal-title":"J Neural Transm"},{"key":"3243_CR32","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1002\/mdc3.13913","volume":"10","author":"HR Moes","year":"2023","unstructured":"Moes HR, Ten Kate JM, Buskens E, Van Laar T (2023b) Patient referral for device-aided therapies in Parkinson\u2019s disease is suboptimal; a Dutch survey. Mov Disord Clin Pract 10:1821\u20131823. https:\/\/doi.org\/10.1002\/mdc3.13913","journal-title":"Mov Disord Clin Pract"},{"key":"3243_CR33","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.45412","author":"Y Naji","year":"2023","unstructured":"Naji Y, Mahdaoui M, Klevor R, Kissani N (2023) Artificial intelligence and multiple sclerosis: up-to-date review. Cureus. https:\/\/doi.org\/10.7759\/cureus.45412","journal-title":"Cureus"},{"key":"3243_CR34","unstructured":"NumPy (2026) https:\/\/numpy.org\/. Accessed 21 May"},{"key":"3243_CR35","doi-asserted-by":"publisher","DOI":"10.1177\/17562864221108018","volume":"15","author":"D Nyholm","year":"2022","unstructured":"Nyholm D, Jost WH (2022) Levodopa\u2013entacapone\u2013carbidopa intestinal gel infusion in advanced Parkinson\u2019s disease: real-world experience and practical guidance. Ther Adv Neurol Disord 15:17562864221108018. https:\/\/doi.org\/10.1177\/17562864221108018","journal-title":"Ther Adv Neurol Disord"},{"key":"3243_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1474-4422(13)70293-X","volume":"13","author":"CW Olanow","year":"2014","unstructured":"Olanow CW, Kieburtz K, Odin P et al (2014) Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson\u2019s disease: a randomised, controlled, double-blind, double-dummy study. Lancet Neurol 13:141\u2013149. https:\/\/doi.org\/10.1016\/S1474-4422(13)70293-X","journal-title":"Lancet Neurol"},{"key":"3243_CR37","unstructured":"OpenRouter. https:\/\/openrouter.ai\/. Accessed 21 May 2026"},{"key":"3243_CR38","unstructured":"pandas - Python Data Analysis Library. https:\/\/pandas.pydata.org\/. Accessed 21 May 2026"},{"key":"3243_CR39","unstructured":"Perktold J, Seabold S, Sheppard K et al (2024) statsmodels\/statsmodels: Release 0.14.2"},{"key":"3243_CR40","unstructured":"Project Jupyter. https:\/\/jupyter.org. Accessed 21 May 2026"},{"key":"3243_CR41","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.parkreldis.2015.04.029","volume":"21","author":"A Puschmann","year":"2015","unstructured":"Puschmann A, Brighina L, Markopoulou K et al (2015) Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: an international consensus statement. Parkinsonism Relat Disord 21:675\u2013682. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.04.029","journal-title":"Parkinsonism Relat Disord"},{"key":"3243_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/s24206658","volume":"24","author":"YA Qadri","year":"2024","unstructured":"Qadri YA, Ahmad K, Kim SW (2024) Artificial general intelligence for the detection of neurodegenerative disorders. Sensors (Basel) 24:6658. https:\/\/doi.org\/10.3390\/s24206658","journal-title":"Sensors (Basel)"},{"key":"3243_CR43","doi-asserted-by":"publisher","first-page":"8384","DOI":"10.1038\/s41467-024-52417-z","volume":"15","author":"P Qiu","year":"2024","unstructured":"Qiu P, Wu C, Zhang X et al (2024) Towards building multilingual language model for medicine. Nat Commun 15:8384. https:\/\/doi.org\/10.1038\/s41467-024-52417-z","journal-title":"Nat Commun"},{"key":"3243_CR44","doi-asserted-by":"crossref","unstructured":"Rashik M, Sweth S, Agrawal N et al (2025) AI-enabled conversational journaling for advancing Parkinson\u2019s disease symptom tracking. In: Proceedings of the 2025 CHI conference on human factors in computing systems, p 1\u201323","DOI":"10.1145\/3706598.3714280"},{"key":"3243_CR45","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1212\/WNL.0000000000207967","volume":"101","author":"MF Romano","year":"2023","unstructured":"Romano MF, Shih LC, Paschalidis IC et al (2023) Large language models in neurology research and future practice. Neurology 101:1058\u20131067. https:\/\/doi.org\/10.1212\/WNL.0000000000207967","journal-title":"Neurology"},{"key":"3243_CR46","doi-asserted-by":"publisher","first-page":"e56762","DOI":"10.2196\/56762","volume":"10","author":"P Ros-Arlanz\u00f3n","year":"2024","unstructured":"Ros-Arlanz\u00f3n P, Perez-Sempere A (2024) Evaluating AI competence in specialized medicine: comparative analysis of ChatGPT and neurologists in a neurology specialist examination in Spain. JMIR Med Educ 10:e56762. https:\/\/doi.org\/10.2196\/56762","journal-title":"JMIR Med Educ"},{"key":"3243_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/7537924","volume":"2020","author":"D Santos-Garc\u00eda","year":"2020","unstructured":"Santos-Garc\u00eda D, De Deus Fonticoba T, Su\u00e1rez Castro E et al (2020) 5-2-1 Criteria: a simple screening tool for identifying advanced PD patients who need an optimization of Parkinson\u2019s treatment. Parkinson\u2019s Dis 2020:1\u20136. https:\/\/doi.org\/10.1155\/2020\/7537924","journal-title":"Parkinson\u2019s Disease"},{"key":"3243_CR48","unstructured":"scikit-learn: machine learning in Python \u2014 scikit-learn 1.8.0 documentation. https:\/\/scikit-learn.org\/stable\/. Accessed 21 May 2026"},{"key":"3243_CR49","unstructured":"SciPy. https:\/\/scipy.org\/. Accessed 21 May 2026"},{"key":"3243_CR50","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000204763","volume":"102","author":"L Shu","year":"2024","unstructured":"Shu L, Mandel D, Tang OY et al (2024) Large language model performance in neurology board questions (S33.001). Neurology 102:2826. https:\/\/doi.org\/10.1212\/WNL.0000000000204763","journal-title":"Neurology"},{"key":"3243_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.eswa.2023.120541","volume":"229","author":"L Sigcha","year":"2023","unstructured":"Sigcha L, Borz\u00ec L, Amato F et al (2023) Deep learning and wearable sensors for the diagnosis and monitoring of Parkinson\u2019s disease: a systematic review. Expert Syst Appl 229:120541. https:\/\/doi.org\/10.1016\/j.eswa.2023.120541","journal-title":"Expert Syst Appl"},{"key":"3243_CR52","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/s41591-024-03423-7","volume":"31","author":"K Singhal","year":"2025","unstructured":"Singhal K, Tu T, Gottweis J et al (2025) Toward expert-level medical question answering with large language models. Nat Med 31:943\u2013950. https:\/\/doi.org\/10.1038\/s41591-024-03423-7","journal-title":"Nat Med"},{"key":"3243_CR53","doi-asserted-by":"publisher","first-page":"396","DOI":"10.5603\/pjnns.105278","volume":"59","author":"J Siuda","year":"2025","unstructured":"Siuda J, To\u015b M, Chmiela T et al (2025) Validation of the polish version of the movement disorder society non-motor rating scale (MDS-NMS). Neurol Neurochir Pol 59:396\u2013402. https:\/\/doi.org\/10.5603\/pjnns.105278","journal-title":"Neurol Neurochir Pol"},{"key":"3243_CR54","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S1474-4422(22)00400-8","volume":"21","author":"MJ Soileau","year":"2022","unstructured":"Soileau MJ, Aldred J, Budur K et al (2022) Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson\u2019s disease: a randomised, double-blind, active-controlled, phase 3 trial. Lancet Neurol 21:1099\u20131109. https:\/\/doi.org\/10.1016\/S1474-4422(22)00400-8","journal-title":"Lancet Neurol"},{"key":"3243_CR55","doi-asserted-by":"publisher","DOI":"10.2196\/67010","volume":"27","author":"X Song","year":"2025","unstructured":"Song X, Wang J, He F et al (2025) Stroke diagnosis and prediction tool using ChatGLM: development and validation study. J Med Internet Res 27:e67010. https:\/\/doi.org\/10.2196\/67010","journal-title":"J Med Internet Res"},{"key":"3243_CR56","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-091563","volume":"15","author":"MJ Stam","year":"2025","unstructured":"Stam MJ, De Neeling MGJ, Keulen BJ et al (2025) AI-DBS study: protocol for a longitudinal prospective observational cohort study of patients with Parkinson\u2019s disease for the development of neuronal fingerprints using artificial intelligence. BMJ Open 15:e091563. https:\/\/doi.org\/10.1136\/bmjopen-2024-091563","journal-title":"BMJ Open"},{"key":"3243_CR57","unstructured":"statsmodels 0.14.6. https:\/\/www.statsmodels.org\/stable\/index.html. Accessed 21 May 2026"},{"key":"3243_CR58","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-080952","volume":"388","author":"D Su","year":"2025","unstructured":"Su D, Cui Y, He C et al (2025) Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ 388:e080952. https:\/\/doi.org\/10.1136\/bmj-2024-080952","journal-title":"BMJ"},{"key":"3243_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mi.2025.289","volume":"6","author":"K Thomas","year":"2025","unstructured":"Thomas K, Edpuganti S, Puthooran D et al (2025) Artificial intelligence in modern clinical practice (review). Med Int 6:1\u201317. https:\/\/doi.org\/10.3892\/mi.2025.289","journal-title":"Med Int"},{"key":"3243_CR60","first-page":"453","volume-title":"International Review of Neurobiology","author":"J Timpka","year":"2017","unstructured":"Timpka J, Nitu B, Datieva V (2017) Device-Aided Treatment Strategies in Advanced Parkinson\u2019s Disease. International Review of Neurobiology. Elsevier, pp 453\u2013474"},{"key":"3243_CR61","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","volume":"25","author":"EJ Topol","year":"2019","unstructured":"Topol EJ (2019) High-performance medicine: the convergence of human and artificial intelligence. Nat Med 25:44\u201356. https:\/\/doi.org\/10.1038\/s41591-018-0300-7","journal-title":"Nat Med"},{"key":"3243_CR62","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5603\/pjnns.109897","volume":"60","author":"M To\u015b","year":"2026","unstructured":"To\u015b M, Dymek A, Siuda J (2026) Infusion therapies for advanced Parkinson\u2019s disease: current evidence and practical challenges \u2014 a narrative review. Neurol Neurochir Pol 60:153\u2013168. https:\/\/doi.org\/10.5603\/pjnns.109897","journal-title":"Neurol Neurochir Pol"},{"key":"3243_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1638340","volume":"17","author":"B Twala","year":"2025","unstructured":"Twala B (2025) AI-driven precision diagnosis and treatment in Parkinson\u2019s disease: a comprehensive review and experimental analysis. Front Aging Neurosci 17:1638340. https:\/\/doi.org\/10.3389\/fnagi.2025.1638340","journal-title":"Front Aging Neurosci"},{"key":"3243_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2020.105633","volume":"196","author":"D Verber","year":"2020","unstructured":"Verber D, Novak D, Borovi\u010d M et al (2020) EQUIDopa: a responsive web application for the levodopa equivalent dose calculator. Comput Methods Programs Biomed 196:105633. https:\/\/doi.org\/10.1016\/j.cmpb.2020.105633","journal-title":"Comput Methods Programs Biomed"},{"issue":"1","key":"3243_CR65","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jama.2008.929","volume":"301","author":"FM Weaver","year":"2009","unstructured":"Weaver FM (2009) Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 301:63. https:\/\/doi.org\/10.1001\/jama.2008.929","journal-title":"JAMA"},{"key":"3243_CR66","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/medicina61010027","volume":"61","author":"J W\u0119grzynek-Gallina","year":"2024","unstructured":"W\u0119grzynek-Gallina J, Chmiela T, Boro\u0144czyk M et al (2024) Satisfaction and preferences for infusion therapies in advanced Parkinson\u2019s disease-patient perspective. Med (Kaunas) 61:27. https:\/\/doi.org\/10.3390\/medicina61010027","journal-title":"Med (Kaunas)"},{"key":"3243_CR67","doi-asserted-by":"crossref","unstructured":"Wei J, Wang X, Schuurmans D et al (2023) Chain-of-thought prompting elicits reasoning in large language models","DOI":"10.52202\/068431-1800"},{"key":"3243_CR68","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1001\/jamaneurol.2025.0905","volume":"82","author":"MB Westover","year":"2025","unstructured":"Westover MB, Westover AM (2025) General AI may revolutionize neurology\u2014or it might be bad. JAMA Neurol 82:977. https:\/\/doi.org\/10.1001\/jamaneurol.2025.0905","journal-title":"JAMA Neurol"},{"key":"3243_CR69","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1002\/mds.29995","volume":"39","author":"A Wijers","year":"2024","unstructured":"Wijers A, Ravi A, Evers SMAA et al (2024) Systematic review of the cost of illness of Parkinson\u2019s disease from a societal perspective. Mov Disord 39:1938\u20131951. https:\/\/doi.org\/10.1002\/mds.29995","journal-title":"Mov Disord"},{"key":"3243_CR70","doi-asserted-by":"publisher","first-page":"1732759","DOI":"10.3389\/fdgth.2025.1732759","volume":"7","author":"DC Wunsch Iii","year":"2026","unstructured":"Wunsch Iii DC, Hier DB (2026) Large language models for neurology: a mini review. Front Digit Health 7:1732759. https:\/\/doi.org\/10.3389\/fdgth.2025.1732759","journal-title":"Front Digit Health"},{"key":"3243_CR71","doi-asserted-by":"publisher","unstructured":"Zhao N, Yang Y, Zhang L et al (2021) Quality of life in Parkinson\u2019s disease: a systematic review and meta-analysis of comparative studies. CNS Neurosci Ther 27:270\u2013279. https:\/\/doi.org\/10.1111\/cns.13549","DOI":"10.1111\/cns.13549"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03243-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-026-03243-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03243-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:25:10Z","timestamp":1784816710000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-026-03243-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":70,"alternative-id":["3243"],"URL":"https:\/\/doi.org\/10.1007\/s00702-026-03243-8","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"31 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}